VMAT2 ligands (Molecular NeuroImaging/Institute for Neurodegenerative Disorders)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVMAT2 ligands (Molecular NeuroImaging/Institute for Neurodegenerative Disorders)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionSynaptic vesicular amine transporter modulators
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsSchizophreniaParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Neuroimaging Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Neurodegenerative Disorders IncMolecular Neuroimaging Llc
Active IndicationsN/A
Inactive IndicationsSchizophreniaParkinson DiseaseHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A